» Articles » PMID: 38385104

COVID-19 Outbreak Trends in Canada, 2021

Overview
Date 2024 Feb 22
PMID 38385104
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In January 2021, the Public Health Agency of Canada launched an outbreak surveillance system, the Canadian COVID-19 Outbreak Surveillance System (CCOSS), with the goal of monitoring incidence and severity of coronavirus disease 2019 (COVID-19) outbreaks across various community settings and complementing case surveillance.

Methods: Seven provinces were included in this report; these provinces submitted weekly cumulative COVID-19 outbreak line lists to CCOSS in 2021. Data includes administrative variables (e.g. date outbreak declared, date outbreak declared over, outbreak identifier), 24 outbreak settings, and number of confirmed cases and outcomes (hospitalization, death). Descriptive analyses for COVID-19 outbreaks across Canada from January 3, 2021, to January 1, 2022, were performed examining trends over time, severity, and outbreak size.

Results: Incidence of outbreaks followed similar trends to case incidence. Outbreaks were most common in school and childcare settings (39%) and industrial/agricultural settings (21%). Outbreak size ranged from 2 to 639 cases per outbreak; the median size was four cases per outbreak. Correctional facilities had the largest median outbreak size with 18 cases per outbreak, followed by long-term care facilities with 10 cases per outbreak. During periods of high case incidence, outbreaks may be under-ascertained due to limited public health capacity, or reporting may be biased towards high-risk settings prioritized for testing. Outbreaks reported to CCOSS were dominated by jurisdictions with the largest populations.

Conclusion: The trends illustrate that COVID-19 outbreaks in 2021 were reported most frequently in community settings such as schools; however, the largest outbreaks occurred in congregate living settings. The information gathered from outbreak surveillance complemented case incidence trends and furthered understanding of COVID-19 in Canada.

Citing Articles

Characterising COVID-19 school and childcare outbreaks in Canada in 2021: a surveillance study.

Patterson K, McGill E, Dam D, Bellos A, Coulby C, McCormick R BMJ Public Health. 2025; 2(1):e000248.

PMID: 40018179 PMC: 11812758. DOI: 10.1136/bmjph-2023-000248.


Risk factors associated with the intensity of COVID-19 outbreaks in Canadian community settings: a retrospective analysis of outbreak-level surveillance data.

Dam D, Chen M, Rees E, Cheng B, Sukkarieh L, McGill E BMC Public Health. 2024; 24(1):2409.

PMID: 39232726 PMC: 11375942. DOI: 10.1186/s12889-024-19853-4.


Responding to and managing multijurisdictional outbreaks of COVID-19 in Canadian industrial worksite/work camp settings.

McGill E, Bellos A, Nwosu A, Zetner A, Tyler A, Knox N Can J Public Health. 2024; 115(3):425-431.

PMID: 38683286 PMC: 11133241. DOI: 10.17269/s41997-024-00887-5.

References
1.
Lin D, Gu Y, Xu Y, Wheeler B, Young H, Sunny S . Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes. JAMA. 2022; 328(14):1415-1426. PMC: 9513711. DOI: 10.1001/jama.2022.17876. View

2.
Murti M, Achonu C, Smith B, Brown K, Kim J, Johnson J . COVID-19 Workplace Outbreaks by Industry Sector and Their Associated Household Transmission, Ontario, Canada, January to June, 2020. J Occup Environ Med. 2021; 63(7):574-580. PMC: 8247533. DOI: 10.1097/JOM.0000000000002201. View

3.
Jarrett M, Schultz S, Lyall J, Wang J, Stier L, De Geronimo M . Clinical Mortality in a Large COVID-19 Cohort: Observational Study. J Med Internet Res. 2020; 22(9):e23565. PMC: 7537718. DOI: 10.2196/23565. View

4.
Fortin E, De Wals P, Talbot D, Ouakki M, Deceuninck G, Sauvageau C . Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, Canada. Can Commun Dis Rep. 2022; 48(4):164-169. PMC: 9017803. DOI: 10.14745/ccdr.v48i04a07. View

5.
Willett B, Grove J, MacLean O, Wilkie C, De Lorenzo G, Furnon W . SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022; 7(8):1161-1179. PMC: 9352574. DOI: 10.1038/s41564-022-01143-7. View